2Seventy Bio Inc Cash Flow-to-Debt Ratio
2Seventy Bio Inc cash flow-to-debt ratio. 2Seventy Bio Inc (TSVT) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2025, meaning its operating cash flow of $-10.97 Million could theoretically repay 0% of its total liabilities ($266.04 Million) in one year. Check cash flow quality index of 2Seventy Bio Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of 2Seventy Bio Inc (2019–2024)
Cash flow-to-debt ratio of 2Seventy Bio Inc from 2019 to 2024. Historical debt coverage capacity for 2Seventy Bio Inc across 6 annual periods. Check 2Seventy Bio Inc (TSVT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
2Seventy Bio Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
2Seventy Bio Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for 2Seventy Bio Inc. For the full cash flow conversion analysis, see TSVT cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.32x | $-85.00 Million | $268.70 Million | ▲ +41.2% |
| 2023 | -0.54x | $-166.86 Million | $310.13 Million | ▲ +21.5% |
| 2022 | -0.68x | $-237.13 Million | $346.20 Million | ▼ -32.3% |
| 2021 | -0.52x | $-207.03 Million | $399.85 Million | ▼ -81.8% |
| 2020 | -0.28x | $-67.79 Million | $237.99 Million | ▲ +62.8% |
| 2019 | -0.77x | $-207.96 Million | $271.26 Million | — |